Your browser doesn't support javascript.
loading
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Condoluci, Adalgisa; Milan, Lisa; Forestieri, Gabriela; Terzi di Bergamo, Lodovico; Spina, Valeria; Bruscaggin, Alessio; Deambrogi, Clara; Moia, Riccardo; Deodato, Marina; Fahrni, Gaby; Mattarucchi, Roberta; Merli, Michele; Gerber, Bernhard; Stussi, Georg; Passamonti, Francesco; Gregor, Michael; Tedeschi, Alessandra; Gaidano, Gianluca; Rossi, Davide; Ceriani, Luca.
Afiliación
  • Condoluci A; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Milan L; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Forestieri G; Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Terzi di Bergamo L; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Spina V; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Bruscaggin A; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Deambrogi C; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
  • Moia R; Department of Translational Medicine, Division of Hematology, University of Eastern Piedmont, Novara, Italy.
  • Deodato M; Department of Translational Medicine, Division of Hematology, University of Eastern Piedmont, Novara, Italy.
  • Fahrni G; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Mattarucchi R; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
  • Merli M; Ospedale di Circolo of Varese & Department of Medicine and Surgery, Hematology, University of Insubria, Varese, Italy.
  • Gerber B; Ospedale di Circolo of Varese & Department of Medicine and Surgery, Hematology, University of Insubria, Varese, Italy.
  • Stussi G; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Passamonti F; University of Zurich, Zurich, Switzerland.
  • Gregor M; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Tedeschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Gaidano G; Ospedale di Circolo of Varese & Department of Medicine and Surgery, Hematology, University of Insubria, Varese, Italy.
  • Rossi D; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.
  • Ceriani L; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Hematol Oncol ; 40(5): 1105-1108, 2022 12.
Article en En | MEDLINE | ID: mdl-35656838
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Suiza